FDA Strengthens Invokana, Farxiga Acute Kidney Injury Risk Warnings
SILVER SPRING, Md. — The Food and Drug Administration on June 14 said it has strengthened the existing warnings for the risk of acute kidney injury on the diabetes drugs Invokana...To view the full article, register now.
Already a subscriber? Click here to view full article